AMANDA LARK: Open Payments
NPI 1841478302 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,823 in 184 payments from 24 companies in 2025. Trend: 2023 $2,623 · 2024 $2,959 · 2025 $3,823
Food & beverage: $2,917Consulting: $750Education: $155
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 2 | $782 |
| Janssen Biotech, Inc. | 25 | $431 |
| Arcutis Biotherapeutics, Inc. | 21 | $345 |
| Regeneron Healthcare Solutions, Inc. | 11 | $309 |
| Galderma Laboratories, L.P. | 16 | $248 |
| Incyte Corporation | 10 | $241 |
| ABBVIE INC. | 19 | $230 |
| UCB, Inc. | 14 | $212 |
| MAYNE PHARMA COMMERCIAL LLC | 18 | $163 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $154 |
Products named: TREMFYA, DUPIXENT, Zoryve, OPZELURA, SKYRIZI, Bimzelx, NEMLUVIO, Sotyktu.
Industry payments across TX — which companies pay providers there.
